advertisement
11.4 Prostaglandins (20)
Showing records 1 to 20
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins51824 Quality of life of glaucoma patients under medical therapy with different prostaglandins
Guedes RA; Guedes VM; Freitas SM; Chaoubah A
Clinical Ophthalmology 2012; 6: 1749-1753
51839 The effect of latanoprost and influence of changes in body position on patients with glaucoma and ocular hypertension
Steigerwalt RD; Vingolo EM; Plateroti P; Nebbioso M
European review for medical and pharmacological sciences 2012; 16: 1723-1728
51887 Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
Rouland JF; Traverso CE; Stalmans I; Fekih LE; Delval L; Renault D; Baudouin C;
British Journal of Ophthalmology 2013; 97: 196-200
51718 Acute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro
Seibold LK; Ammar DA; Kahook MY
Current Eye Research 2013; 38: 70-74
51736 Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension
Swymer C; Neville MW
Annals of Pharmacotherapy 2012; 46: 1506-1510
51955 Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost
Sakata R; Shirato S; Miyata K; Aihara M
Japanese Journal of Ophthalmology 2013; 57: 179-184
51855 Neurogenic contractions in intraocular porcine ciliary arteries are mediated by α₂-adrenoceptors and NPY₁ receptors and are inhibited by prostaglandin E₂ acting on prejunctional EP₄ receptors
Kringelholt S; Simonsen U; Bek T
Experimental Eye Research 2013; 107: 32-36
51950 Prostaglandin Analogs and Timolol-Fixed Versus Unfixed Combinations or Monotherapy for Open-Angle Glaucoma: A Systematic Review and Meta-Analysis
Quaranta L; Biagioli E; Riva I; Rulli E; Poli D; Katsanos A; Floriani I
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 382-389
52027 Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
Liu Y; Mao W
Clinical Ophthalmology 2013; 7: 7-14
51751 The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias
Khidhir KG; Woodward DF; Farjo NP; Farjo BK; Tang ES; Wang JW; Picksley SM; Randall VA
FASEB Journal 2013; 27: 557-567
51713 Effect of Latanoprost on Central Corneal Thickness in Unilateral Normal-Tension Glaucoma
You JY; Cho BJ
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 335-338
51947 The effect of topical latanoprost on anterior segment anatomic relationships in normal dogs
Tsai S; Almazan A; Lee SS; Li H; Conforti P; Burke J; Miller PE; Robinson MR
Veterinary Ophthalmology 2013; 16: 370-376
51667 The effects of prostaglandin analogues on intracellular Ca2+ in ciliary arteries of wild-type and prostanoid receptor-deficient mice
Abe S; Watabe H; Takaseki S; Aihara M; Yoshitomi T
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 55-60
51657 Adverse periocular reactions to five types of prostaglandin analogs
Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
Eye 2012; 26: 1465-1472
51745 Possible mechanism for the gastro-intestinal adverse effects upon topical application of Prostaglandin F₂α analogs
Cai S; Zhou X; Yan N; Liu X; Li X
Medical Hypotheses 2013; 80: 32-35
51995 An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
Nixon DR; Simonyi S; Bhogal M; Sigouin CS; Crichton AC; Discepola M; Hutnik CM; Yan DB
Clinical Ophthalmology 2012; 6: 2097-2103
51895 Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases
Yoshino T; Fukuchi T; Togano T; Seki M; Ikegaki H; Abe H
Japanese Journal of Ophthalmology 2013; 57: 172-178
52046 A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma
Long DD; Frieman B; Hegde SS; Hill CM; Jiang L; Kintz S; Marquess DG; Purkey H; Shaw JP; Steinfeld T; Wilson MS; Wrench K
Bioorganic and Medicinal Chemistry Letters 2013; 23: 939-943
51724 A patient with corneal epithelial disorder that developed after administration of a latanoprost generic, but not a brand-name drug, eye drop
Takada Y; Okada Y; Fujita N; Saika S
Case reports in ophthalmological medicine 2012; 2012: 536746
51880 Current status of unoprostone for the management of glaucoma and the future of its use in the treatment of retinal disease
Harms NV; Toris CB
Expert Opinion in Pharmacotherapy 2013; 14: 105-113
